US reclassifies medical marijuana

Acting Attorney General Todd Blanche signed the directive on Thursday, marking one of the most significant changes to federal drug policy in decades.

The reclassification applies specifically to FDA-approved and state-regulated medical products, rather than full federal legalization.

Supporters argue the move will allow for more robust scientific study of the drug's therapeutic benefits.

However, critics like Senator Tom Cotton warn that the policy could lead to increased public health risks and psychosis.